541304 — Indo US Bio-Tech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹3.26bn
- IN₹3.40bn
- IN₹728.36m
- 89
- 12
- 16
- 31
Annual cashflow statement for Indo US Bio-Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28.6 | 39.3 | 53.1 | 73.9 | 88 |
| Depreciation | |||||
| Non-Cash Items | 9.22 | 11.7 | 12 | 11.9 | 14.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -47.8 | -52 | -42.5 | -88.8 | -156 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.85 | 1.58 | 27 | 5.26 | -45.8 |
| Capital Expenditures | -3.96 | -19.5 | -39.7 | -18.2 | -26.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.91 | 1.74 | -14.8 | -48.5 | 68.9 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.87 | -17.8 | -54.4 | -66.7 | 42.8 |
| Financing Cash Flow Items | -8.84 | -11.7 | -11.7 | -11.8 | -15.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.9 | 15.5 | 26.5 | 62.9 | 12.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.18 | -0.66 | -0.852 | 1.41 | 9.09 |